Use of cholesterol- and blood pressure lowering medications: trends, determinants and socio-economic disparities
|Funding:||Health Economics Research Centre, University of Oxford|
|Collaborators:||Dmitrij Achelrod, Hamburg University; David Preiss, University of Oxford|
Cholesterol- and blood pressure-lowering medications, shown to be effective and cost-effective in reducing cardiovascular risk and recommended in clinical guidelines, have been at the forefront of cardiovascular prevention. However, whilst improving, their use has remained suboptimal even in high-income countries with comprehensive healthcare provision. The aim of the project is to investigate the trends of use of cholesterol- and blood pressure lowering interventions and the role of socioeconomic, behavioural and cognitive factors using large population surveys.
Associate Professor and University Research Lecturer
+44 (0)1865 289226
Professor of Health Economics, Director, HERC
+44 (0)1865 289279
Achelrod D, Gray A, Preiss D, Mihaylova B. Cholesterol and blood-pressure lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe. Eur J Prev Cardiol 2016:2047487316676906.